Presenters of The Value of Ready-to-Administer Products: Pharmacy Data Insights will highlight evidence for the safety and cost-effectiveness of Ready-to-Administer (RTA) prefilled syringes compared to the traditional vial-and-syringe method.  The peer-reviewed literature discussed in this interactive session enables real-world action supporting an institution-specific value proposition for use of RTA prefilled syringes. New research into the pharmacy-related cost impact will also be introduced as part of a complete cost assessment of RTA for health-systems.